Risk prediction of pleural effusion in lung malignancy patients treated with CT-guided percutaneous microwave ablation: a nomogram and artificial neural network model

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Mazzone P. Preoperative evaluation of the lung resection candidate. Cleveland Clin J Med. 2012;79(5):S17–S22.
   Google Scholar
• Liu H, Steinke K. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study. J Med Imaging Radiat Oncol. 2013;57(4):466–474.
   PubMed Web of Science ®Google Scholar
• Quirk MT, Lee S, Murali N, et al. Alternatives to surgery for early-stage non-small cell lung cancer: thermal ablation. Clin Chest Med. 2020;41(2):197–210.
   PubMed Web of Science ®Google Scholar
• Iezzi R, Cioni R, Basile D, et al. Standardizing percutaneous microwave ablation in the treatment of lung tumors: a prospective multicenter trial (MALT study). Eur Radiol. 2020. DOI:https://doi.org/10.1007/s00330-020-07299-2. Online ahead of print.
   Web of Science ®Google Scholar
• Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(4):v1–v21.
   Web of Science ®Google Scholar
• Donington J, Ferguson M, Mazzone P, et al. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012;142(6):1620–1635.
   PubMed Web of Science ®Google Scholar
• Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137(1):160–166.
   PubMed Web of Science ®Google Scholar
• Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241(1):275–283.
   PubMed Web of Science ®Google Scholar
• Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol. 2008;31(1):122–130.
   PubMed Web of Science ®Google Scholar
• Nomura M, Yamakado K, Nomoto Y, et al. Complications after lung radiofrequency ablation: risk factors for lung inflammation. BJR. 2008;81(963):244–249.
   Google Scholar
• Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247(3):871–879.
   PubMed Web of Science ®Google Scholar
• Zheng A, Wang X, Yang X, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg. 2014;98(1):243–248.
   PubMed Web of Science ®Google Scholar
• Tajiri N, Hiraki T, Mimura H, et al. Measurement of pleural temperature during radiofrequency ablation of lung tumors to investigate its relationship to occurrence of pneumothorax or pleural effusion. Cardiovasc Intervent Radiol. 2008;31(3):581–586.
   PubMed Web of Science ®Google Scholar
• Splatt AM, Steinke K. Major complications of high-energy microwave ablation for percutaneous CT-guided treatment of lung malignancies: single-centre experience after 4 years. J Med Imaging Radiat Oncol. 2015;59(5):609–616.
   PubMed Web of Science ®Google Scholar
• Kashima M, Yamakado K, Takaki H, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. AJR Am J Roentgenol. 2011;197(4):W576–W580.
   PubMed Web of Science ®Google Scholar
• Hiraki T, Gobara H, Fujiwara H, et al. Lung cancer ablation: complications. Semin Intervent Radiol. 2013;30(02):169–175.
   PubMed Web of Science ®Google Scholar
• Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24(24):3967–3972.
   PubMed Web of Science ®Google Scholar
• Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet. 1995;346(8982):1075–1079.
   PubMed Web of Science ®Google Scholar
• Baxt WG. Application of artificial neural networks to clinical medicine. Lancet. 1995;346(8983):1135–1138.
   PubMed Web of Science ®Google Scholar
• Song SG, Hur YH, Cho JY, et al. Pleural effusion after hepatic radiofrequency ablation with artificial ascites: clinical spectrum and significance. J Vasc Interv Radiol. 2020;31(10):1636–1644.
   PubMed Web of Science ®Google Scholar
• Lim W, Ridge CA, Nicholson AG, et al. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018;8(7):709–718.
   PubMed Web of Science ®Google Scholar
• Venturini M, Cariati M, Marra P, et al. CIRSE standards of practice on thermal ablation of primary and secondary lung tumours. Cardiovasc Intervent Radiol. 2020;43(5):667–683.
   PubMed Web of Science ®Google Scholar
• Wang D, Li B, Bie Z, et al. Synchronous core-needle biopsy and microwave ablation for highly suspicious malignant pulmonary nodule via a coaxial cannula. J Cancer Res Ther. 2019;15(7):1484–1489.
   PubMed Web of Science ®Google Scholar
• Xu S, Guan LJ, Shi BQ, et al. Recurrent hemoptysis after bronchial artery embolization: prediction using a nomogram and artificial neural network model. AJR Am J Roentgenol. 2020;215:1490–1498.
   PubMed Web of Science ®Google Scholar
• Hinshaw JL, Lubner MG, Ziemlewicz TJ, et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation-what should you use and why? Radiographics. 2014;34(5):1344–1362.
   PubMed Web of Science ®Google Scholar
• Egashira Y, Singh S, Bandula S, et al. Percutaneous high-energy microwave ablation for the treatment of pulmonary tumors: a retrospective single-center experience. J Vasc Interv Radiol. 2016;27(4):474–479.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Roman A, Nour-Eldin NA, et al. A comparison between 915 MHz and 2450 MHz microwave ablation systems for the treatment of small diameter lung metastases. Diagn Interv Radiol. 2018;24(1):31–37.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Basten LM, Nour-Eldin NA, et al. Microwave ablation (MWA) of pulmonary neoplasms: clinical performance of high-frequency MWA with spatial energy control versus conventional low-frequency MWA. Am J Roentgenol. 2019;213(6):1388–1396.
   PubMed Web of Science ®Google Scholar
• Kodama H, Ueshima E, Gao S, et al. High power microwave ablation of normal swine lung: impact of duration of energy delivery on adverse event and heat sink effects. Int J Hyperthermia. 2018;34(8):1186–1193.
   PubMed Web of Science ®Google Scholar
• Prud’homme C, Teriitehau C, Adam J, et al. Lung microwave ablation - an in vivo swine tumor model experiment to evaluate ablation zones. Int J Hyperthermia. 2020;37(1):879–886.
   PubMed Web of Science ®Google Scholar
• Han X, Yang X, Huang G, et al. Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: a multicenter retrospective study. Thorac Cancer. 2019;10(12):2236–2242.
   PubMed Web of Science ®Google Scholar